Sergi Figuerola appointed new director of the I2CAT Foundation

Succeeds Prof. Josep Paradells, who took up the management of the institute at the end of 2015

Dr Sergi Figuerola Fernández has been appointed new director of the i2CAT Foundation by the board of trustees in a meeting held last January 17th. Figuerola succeeds the professor of the Polytechnic University of Catalonia (UPC) Josep Paradells, who led the entity since October 2015.

Sergi Figuerola is a Telecommunication Engineer and PhD in Telecommunication Engineering from the Department of Theory and Communication of Signals of the UPC, PDG-2019 for IESE and Master in Project Management for La Salle (URL). He joined the i2CAT Foundation in 2004 as coordinator of the Technologies Network Area, becoming director of the Networks and Distributed Applications Area in 2010 and Chief Technology and Information Officer (CTIO) in 2013.

In the last twenty years, he has participated in leading roles in various research projects funded by the European Commission in the field of telecommunications, 5G and the new generation of the Internet, and has contributed to more than 50 scientific publications. Currently, he is a member of different technical programs of international conferences and evaluator of projects and national and international research programs. He will also participate as a coordinator in the definition of the New Space strategy of the Government of Catalonia.

In the words of the new director, “it is an honour to assume this role, and I am committed to working so that the centre continues to generate impact through research and innovation of excellence. The talent of the i2CAT team is the cornerstone, and I have the certainty I will continue to support an environment that promotes collaboration with the solid foundation of the mission, vision and values of the centre. i2CAT stands out because it acts as a unique link between the academic, public and private sectors, but now our goal is going further to contribute to the transformation of the Catalan ecosystem and creating an advanced digital society in Catalonia”.

Figuerola will work to “consolidate the institution, strengthen sectors and technologies and to position i2CAT as a leading European centre in R+D+I and prepare it for the future”.

Dr Sergi Figuerola.

I3PT opens call for director

I3PT is seeking applicants with a proven-track record in leadership, a distinguished record of scientific excellence and the innovative thinking necessary to lead a dynamic organization. The elected candidate must meet the challenge of increasing the scientific level of the I3PT and boosting the institute’s translational research being carried out.

The I3PT is an equal opportunities employer and female candidates are strongly encouraged to send their applications.

I3PT’s mission is to promote an environment that favours translational research to improve the health of people, with a vision to be a biomedical research centre that contributes to be a leading international institution in healthcare innovation that promotes clinical and translational research, recognized for developing a healthcare, organizational, teaching and research model of excellence focused on the patient and the effective generation of wealth.

Application deadline ends February 15th.

Marina Mosquera Martínez, new director of IPHES-CERCA

She will succeed Robert Sala i Ramos, who has held this position for the last eight years.

The Board of Trustees of the Institut Català de Paleoecologia Humana i Evolució Social (IPHES) has appointed Dr Marina Mosquera Martínez as the new director of the institute in a meeting hold on Wednesday 27 December with the participation of all members.
Dr Mosquera, who is a professor at the Universitat Rovira Virgili (URV) and an associated researcher of IPHES since its inception, holds a PhD in History, with more than seventy publications. She focus her research in the first occupations of the European subcontinent, technology and behaviour, and the evolution of cognition and the origin of technological behaviour through ethoprimatology.

The appointment follows an international selection process coordinated by the CERCA Institution with the participation of the IPHES-CERCA External Scientific Advisory Board. Dr Marina Mosquera will be the third director of the centre, succeeding Dr Robert Sala i Ramos, who has been director of the centre during eight years and Dr. Eudald Carbonell, who was its founding director.

Dr Marina Mosquera Martínez, new director of IPHES-CERCA.
Dr Marina Mosquera Martínez, new director of IPHES-CERCA.

Quique Bassat will be the new Director General of the Barcelona Institute for Global Health

Bassat will succeed Antoni Plasència, who has held this position since October 2014.

The Board of Trustees of the Barcelona Institute for Global Health (ISGlobal) has appointed Quique Bassat as the new Director General of the institution. Bassat will succeed Antoni Plasència, who has led the institution since October 2014.

A paediatrician and epidemiologist, Quique Bassat is ICREA Research Professor and Director of the Malaria and Neglected Parasitic Diseases programme at ISGlobal, as well as Associate Professor at the University of Barcelona and researcher at Hospital Sant Joan de Déu. Throughout his professional career, which has included long stays in the Manhiça Health Research Centre (CISM), in Mozambique, he has combined his clinical work with biomedical research on infectious diseases affecting the poorest and most vulnerable populations, with his two main areas of interest being childhood malaria and respiratory infections (bacterial or viral).

“I am honoured and thrilled by this opportunity that the Board of Trustees has given me,” says Bassat. “ISGlobal plays a critical role in advancing global health and equity, and I look forward to continuing to work with the incredible team of professionals that make up ISGlobal in my new role to further our positive impact around the world.

A rigorous selection process

On behalf of the Executive Committee of ISGlobal’s Board of Trustees, a selection committee made up of experts appointed by the Board of Trustees, with the support of the CERCA system of the Generalitat de Catalunya, carried out the selection process for the new director through a public and international call for applications. From the list of applications received, a group of highly qualified candidates were interviewed to assess their scientific solvency, management skills and strategic proposals for ISGlobal. Quique Bassat was the unanimous choice because of his proven scientific, clinical and translational track record and his commitment to ISGlobal’s mission and values. His experience in the field, his ability to lead multidisciplinary teams and his innovative vision were key aspects in the Committee’s final assessment.

In relation to the change of Director, the Board of Trustees expresses its deep gratitude to the outgoing director, Antoni Plasència, for his strong commitment and exemplary leadership, and expresses its full confidence in his successor, Quique Bassat. “Through a rigorous selection process we have chosen the best candidate to lead this new cycle. The “la Caixa” Foundation is proud to continue to support ISGlobal in its strategy to address the major global health challenges and promote equity in health through excellence in research and the transfer and application of knowledge”, said Javier Solana, Chairman of the Executive Committee of ISGlobal.

L’I2CAT opens call for Director

The Director must contribute to increasing the research level of i2CAT and the impact it has on the Public and Private sectors while boosting digital societal activities aiming at minimizing the territory digital divide.

The qualities being sought in the Director include outstanding strategic vision, integrity, communication skills, administrative abilities, energy and motivation, fundraising experience, consensus building capacity, and a leadership style that engenders and nurtures trust and respect. She/He will have an excellent record in technology, research, leadership experience, capacity of team management, and will embrace the values of rigour, diversity, and service, and provide inspiration to all staff. She/He will have an in-depth knowledge of both national and international research systems and ecosystems – with a particular focus on European programs.

i2CAT wants to lead the challenge of designing the digital society of the future based on research and innovation in advanced digital technologies. Through talent generation, cooperation, and the commitment of its members, i2CAT envisions Catalonia as a creative, empowered, and innovative society, where knowledge and digital technology are at the service of the Catalan ecosystem and society.

Deadline for submitting applications: October 13th, 2023 at 9 am ECT

ISGLOBAL-CERCA opens call for applications: ISGlobal Director General

This call for applications is aimed at the selection of the best candidate for the position of Director General of ISGlobal, and is open to candidates worldwide including those who are currently or have been researchers at ISGlobal.

The Barcelona Institute for Global Health (ISGlobal) is a cutting-edge institution addressing global and public health challenges through research, innovation, translation into policy and education. It is the result of a private-public partnership involving highly reputed academic, public administration and philanthropic institutions.

ISGlobal has a broad research portfolio in communicable and non-communicable diseases including environmental and climate determinants of health, and applies a multidisciplinary scientific approach ranging from the molecular to the population level. Research is organised in the following five programmes: Malaria and neglected parasitic diseases; Maternal, Child and reproductive Health; Global Viral and Bacterial Infections; Climate, air pollution, nature and urban health; and Environment and health over the lifecourse.

ISGlobal is a private center promoted by “la Caixa” Foundation and takes part in the CERCA system of the Generalitat of Catalunya. It is accredited with the Severo Ochoa distinction, a seal of excellence from the Spanish Science Ministry, strengthening cross-cutting frontier methodological capabilities in areas of Data sciences, Health Impact Assessment and eHealth.

The deadline to receive applications is September the 15th, 2023, 10pm ECT.

ICRA-CERCA opens call for director

ICRA’s mission is to be a point of reference for water science and technology in the Mediterranean.

The centre produces multidisciplinary water research with the ambition to cover the complete water cycle, from freshwater ecosystems, tracking the water quality and quantity, water depuration, reutilization, and the return to the ecosystem in the best conditions. Its research focuses on the rational use and effects of human activities on water resources and aquatic ecosystems, based on the fundamental importance of water as a resource.

ICRA is a research institute from the CERCA System of the Catalan Government. It is also supported by the Catalan Water Agency (ACA) and the University of Girona (UdG), from which it is an attached research institute.

The deadline for submitting nominations ends on September 30, 2023.

The ICFO-CERCA opens a call for director

ICFO’s research is world-class and encompasses broad fundamental and applied themes relevant to medicine and biology, advanced imaging techniques, information technologies, a range of sensors, tunable and ultra-fast lasers, the properties and applications of nano and quantum materials, and quantum science and technologies.

ICFO is a CERCA research center affiliated to the Universitat Politècnica de Catalunya- Barcelona Tech, located in the Mediterranean Technology Park, in Castelldefels, in the Barcelona metropolitan area. It was created in 2002 and currently hosts 450 people, organized in 25 research teams.

Application Deadline: 29 Sep 2023 – 22:00 (Europe/Madrid)

The IPHES-SERCA opens a call for director

The Catalan Institute of Human Paleoecology and Social Evolution (IPHES-CERCA) has announced an open call for direction.

IPHES-CERCA is seeking applicants with a distinguished record of scientific excellence and the innovative thinking necessary to lead a dynamic organisation.

The deadline for submitting nominations ends on October 5, 2023.

Daniel Maspoch, PI at ICN2-CERCA and ICREA professor, acknowledged with Rei Jaume I Award to New Technologies

  • His groundbreaking research and successful translation of academic concepts into industrial applications have fuelled considerable progress in the domain of material science.

 Renowned chemist ICREA Prof. Daniel Maspoch Comamala, Group Leader of the ICN2-CERCA Supramolecular NanoChemistry and Materials Group, has been distinguished with the New Technologies Rei Jaume I award at the illustrious Rei Jaume I Awards ceremony. The judging panel of the Rei Jaume I Awards selected the winners in six distinct categories this morning.

In addition to the Prof. Maspoch’s recognition to his remarkable contributions to the sphere of new technologies, six other scientific profiles have been awarded in different categories: Antonio Echavarren Pablos (Basic Research); Olympia Bover Hidiroglu (Economics); Guillermina López-Bendito (Medical Research); Carlota Escutia Dotti (Environmental Protection) and Alfonso Jiménez Rodríguez-Vila (Entrepreneurship award).

ICREA Prof. Daniel Maspoch has garnered widespread acclaim across academia, industry, and society for his research impact. His endeavours in the synthesis of reticular materials, comprising metal-organic frameworks (MOFs), covalent-organic frameworks (COFs), and metal-organic polyhedra (MOPs), have instigated a paradigm shift in the domain of material science.

Alongside his work on microscopic ‘spongy’ materials, Prof. Maspoch’s Group has also created new systems to selectively deliver medicines. His team, collaborating with hospitals and research institutes, has made promising strides in developing ways to treat diseases like diabetes and multiple sclerosis. This has led to him co-founding Ahead Therapeutics in 2017, a company that’s currently working on several new treatments for autoimmune diseases.